Mike D. Burns
Director/Miembro de la Junta en CureLab Oncology, Inc. .
Perfil
Mike D.
Burns is currently an Independent Director at CureLab Oncology, Inc. He previously held positions as a Managing Director at TL Ventures, Inc., a Director at Texas Instruments Lehigh Valley, Inc., and a Director-Business Development at Agere, Inc. From 2011 to 2020, he served as the Managing Partner at Alara Capital LLC.
Mr. Burns obtained his undergraduate degree from the University of Pennsylvania, his graduate degree from Moore College of Art & Design, and another undergraduate degree from The Wharton School of the University of Pennsylvania.
Cargos activos de Mike D. Burns
| Empresas | Cargo | Inicio |
|---|---|---|
CureLab Oncology, Inc.
 CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Mike D. Burns.
| Empresas | Cargo | Fin |
|---|---|---|
Alara Capital LLC
 Alara Capital LLC Investment ManagersFinance Alara Capital LLC (Alara Capital) is a venture capital/private equity firm founded in 2005. The firm is headquartered in Austin, Texas. | Inversor de Capital Privado | 01/01/2020 |
| Agere, Inc. | Corporate Officer/Principal | - |
Texas Instruments Lehigh Valley, Inc.
 Texas Instruments Lehigh Valley, Inc. SemiconductorsElectronic Technology Texas Instruments Lehigh Valley, Inc. designs and develops radio frequency power semiconductor solutions. The company was founded by Mark E. Granahan in 2004 and is headquartered in Bethlehem, PA. | Director/Miembro de la Junta | - |
TL Ventures, Inc.
 TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Inversor de Capital Privado | - |
Formación de Mike D. Burns.
| University of Pennsylvania | Undergraduate Degree |
| Moore College of Art & Design | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
TL Ventures, Inc.
TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Finance |
Texas Instruments Lehigh Valley, Inc.
Texas Instruments Lehigh Valley, Inc. SemiconductorsElectronic Technology Texas Instruments Lehigh Valley, Inc. designs and develops radio frequency power semiconductor solutions. The company was founded by Mark E. Granahan in 2004 and is headquartered in Bethlehem, PA. | Electronic Technology |
| Agere, Inc. | Industrial Services |
Alara Capital LLC
Alara Capital LLC Investment ManagersFinance Alara Capital LLC (Alara Capital) is a venture capital/private equity firm founded in 2005. The firm is headquartered in Austin, Texas. | Finance |
CureLab Oncology, Inc.
CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Mike D. Burns
